- Home
- SERA vs PCM Comparison
SERA vs PCM Comparison
Compare SERA & PCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SERA | PCM |
|---|---|---|
| Founded | 2008 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 82.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SERA | PCM |
|---|---|---|
| Price | $1.95 | $5.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 30.9K | ★ 53.7K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.68% |
| EPS Growth | ★ 32.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,000.00 | N/A |
| Revenue This Year | $554.81 | N/A |
| Revenue Next Year | $517.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.19 | N/A |
| 52 Week Low | $1.56 | $5.48 |
| 52 Week High | $3.95 | $6.76 |
Technical Indicators
Market Signals| Indicator | SERA | PCM |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 62.41 |
| Support Level | $1.85 | $5.65 |
| Resistance Level | $2.03 | $5.83 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 60.53 | 78.38 |
Price Performance
Historical ComparisonAbout SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About PCM PCM Fund Inc.
Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.